Cargando…

Development and internal validation of a diagnostic prediction model for psoriasis severity

BACKGROUND: While administrative health records such as national registries may be useful data sources to study the epidemiology of psoriasis, they do not generally contain information on disease severity. OBJECTIVES: To develop a diagnostic model to distinguish psoriasis severity based on administr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liljendahl, Mie Sylow, Loft, Nikolai, Egeberg, Alexander, Skov, Lone, Nguyen, Tri-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903561/ https://www.ncbi.nlm.nih.gov/pubmed/36747306 http://dx.doi.org/10.1186/s41512-023-00141-5

Ejemplares similares

A nationwide population‐based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark
por: Loft, Nikolai, et al.
Publicado: (2022)

Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
por: SCHWARZ, Christopher Willy, et al.
Publicado: (2021)

Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study
por: LOFT, Nikolai, et al.
Publicado: (2021)

Childhood asthma is associated with development of type 1 diabetes and inflammatory bowel diseases: a Danish nationwide registry study
por: Liljendahl, Mie Sylow, et al.
Publicado: (2022)

Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in Denmark
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2022)

Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis
por: Andersen, Clara Sophie Bramsen, et al.
Publicado: (2023)

Comorbidities, socioeconomic status, drug use, and health care consumption in Danish women with psoriasis: A nationwide cross-sectional study
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2020)

Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study
por: LOFT, Nikolai, et al.
Publicado: (2023)

Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)
por: Gyldenløve, Mette, et al.
Publicado: (2023)

Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis
por: Loft, Nikolai Dyrberg, et al.
Publicado: (2018)

Effect of Anti-interleukin-17 Treatment on Haemoglobin A1c Levels
por: SCHWARZ, Christopher Willy, et al.
Publicado: (2020)

Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
por: Näslund-Koch, Charlotte, et al.
Publicado: (2020)

Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014)

Erratum to: Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma
por: Andersen, Yuki M. F., et al.
Publicado: (2017)

Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma
por: Andersen, Yuki M.F., et al.
Publicado: (2017)

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
por: Haulrig, Morten B, et al.
Publicado: (2021)

Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
por: Kvist-Hansen, Amanda, et al.
Publicado: (2019)

Characterization of the Oral and Gut Microbiota in Patients with Psoriatic Diseases: A Systematic Review
por: TODBERG, Tanja, et al.
Publicado: (2021)

Smoking is an independent but not a causal risk factor for moderate to severe psoriasis: A Mendelian randomization study of 105,912 individuals
por: Näslund-Koch, Charlotte, et al.
Publicado: (2023)

Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
por: Todberg, Tanja, et al.
Publicado: (2020)

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
por: Kirkham, Bruce W., et al.
Publicado: (2023)

Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort
por: Egeberg, Alexander, et al.
Publicado: (2019)

Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
por: Blegvad, Christoffer, et al.
Publicado: (2019)

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort
por: Egeberg, Alexander, et al.
Publicado: (2020)

Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument: a disease‐specific measure of quality of life in adolescents with psoriasis
por: Randa, H., et al.
Publicado: (2020)

Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
por: Egeberg, Alexander, et al.
Publicado: (2023)

Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review
por: AMIRI, Diva, et al.
Publicado: (2023)

IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis
por: Wang, Xing, et al.
Publicado: (2022)

Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis
por: NÄSLUND-KOCH, Charlotte, et al.
Publicado: (2022)

The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
por: Wu, Jashin J., et al.
Publicado: (2022)

Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries
por: Balieva, Flora Nicol, et al.
Publicado: (2023)

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
por: Egeberg, Alexander, et al.
Publicado: (2023)

Validity of Diagnostic Codes for Identification of Psoriasis Patients in Korea
por: Ham, Seung Pil, et al.
Publicado: (2020)

Development of clinical diagnostic criteria for plaque psoriasis in children: an electronic Delphi consensus study with the International Psoriasis Council
por: Burden‐Teh, E., et al.
Publicado: (2019)

Can patient-reported outcome measures be used to predict consultation needs in patients with psoriasis?: A survey study
por: Krontoft, Anna Sophie Belling, et al.
Publicado: (2022)

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses
por: Warren, Richard B., et al.
Publicado: (2019)

Duration of psoriatic arthritis as a risk factor for myocardial infarction
por: Egeberg, Alexander, et al.
Publicado: (2018)

Recruitment and Retention in a Randomized Control Trial of Increased Dietary Protein-to-Carbohydrate Ratios in Patients with Psoriasis
por: Anders Nikolai Ørsted, SCHULTZ, et al.
Publicado: (2020)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tsto1kuso24jvjoiou502m9psa